Evidence map›Paper›PMID 30430755›Full record

ArticleMacromolecular bioscience2019

Two-Photon Polymerization as a Tool for Studying 3D Printed Topography-Induced Stem Cell Fate.

Kristan S Worthington, Anh-Vu Do, Rasheid Smith, Budd A Tucker, Aliasger K Salem

Abstract read
In one paragraph

Article in Macromolecular bioscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Applications of nanotechnology in 3D printed tissue engineering scaffolds.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kristan S WorthingtonDepartment of Biomedical Engineering, College of Engineering, The University of Iowa, Iowa City, IA, 52242, USA.ORCID 0000-0002-0693-0685
Anh-Vu DoDepartment of Pharmaceutics and Translational Therapeutics, College of Pharmacy, The University of Iowa, Iowa City, IA, 52242, USA.
Rasheid SmithDepartment of Pharmaceutics and Translational Therapeutics, College of Pharmacy, The University of Iowa, Iowa City, IA, 52242, USA.
Budd A TuckerInstitute for Vision Research, Department of Ophthalmology and Visual Science, Carver College of Medicine, The University of Iowa, Iowa City, IA, 52242, USA.ORCID 0000-0003-2178-1742
Aliasger K SalemDepartment of Pharmaceutics and Translational Therapeutics, College of Pharmacy, The University of Iowa, Iowa City, IA, 52242, USA.ORCID 0000-0002-1923-6633

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Choriocapillaris Protection and Replacement in AMDR01EY024605 · NEI · UNIVERSITY OF IOWA · PI Robert Foster Mullins, Budd A Tucker · 2014 to 2026
$4.6M
Development of a cell replacement therapy to treat retinal degenerative blindnessDP2OD007483 · OD · UNIVERSITY OF IOWA · PI TUCKER, BUDD A · 2010 to 2010
$2.3M
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: LUNGS10RR022498 · NCRR · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2006 to 2006
$445k
Holden Comprehensive Cancer CenterLyle and Sharon Bighley Chair of Pharmaceutical SciencesNCI NIH HHS P30 CA086862NCRR NIH HHS S10 RR022498NEI NIH HHS R01 EY024605NIEHS NIH HHS P30 ES005605NIH HHS 1 DP2 OD007483-01NIH HHS 1 R01 024605-01NIH HHS 5P30CA086862NIH HHS DP2 OD007483Office of the Vice President for Research and Economic DevelopmentRoy J. and Lucille A. Carver College of Medicine at the University of IowaRoy J. Carver Charitable Trust 18-5045Roy J. Carver Charitable Trust 1 S10 RR022498-01
6 · The paper itself

Abstract

Geometric topographies are known to influence cellular differentiation toward specific phenotypes, but to date the range of features and type of substrates that can be easily fabricated to study these interactions is somewhat limited. In this study, an emerging technology, two-photon polymerization, is used to print topological patterns with varying feature-size and thereby study their effect on cellular differentiation. This technique offers rapid manufacturing of topographical surfaces with good feature resolution for shapes smaller than 3 µm. Human-induced pluripotent stem cells, when attached to these substrates or a non-patterned control for 1 week, express an array of genetic markers that suggest their differentiation toward a heterogeneous population of multipotent progenitors from all three germ layers. Compared to the topographically smooth control, small features (1.6 µm) encourage differentiation toward ectoderm while large features (8 µm) inhibit self-renewal. This study demonstrates the potential of using two-photon polymerization to study and control stem cell fate as a function of substrate interactions. The ability to tailor and strategically design biomaterials in this way can enable more precise and efficient generation or maintenance of desired phenotypes in vitro and in vivo.

Indexed as

Printing, Three-DimensionalBiocompatible MaterialsCell DifferentiationCells, CulturedGenetic MarkersHumansInduced Pluripotent Stem CellsPolymerizationSurface PropertiesBiocompatible MaterialsGenetic Markers3D printingdifferentiationinduced pluripotent stem cellssubstrate topographytwo-photon polymerization

Identifiers

PMID30430755
PMCPMC6365162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.